Study of the pharmacokinetics of polymerized porcine hemoglobin (pPolyHb).

Study of the pharmacokinetics of polymerized porcine hemoglobin (pPolyHb).

Artif Cells Nanomed Biotechnol. 2018 Mar 11;:1-7

Authors: Shen Y, Zhu W, Zhao M, Zhao G, Niu G, Bai Y, Yang B, Chen C, Zhu H

Abstract
Polymerized porcine hemoglobin (pPolyHb), a kind of glutaraldehyde-polymerized haemoglobin-based oxygen carrier, was developed as a potential red blood substitute for clinical applications. Assessment of its absorption, distribution, and metabolism is a major determinant of its safety and efficacy. In this study, a series of pharmacokinetic parameters of pPolyHb were measured and calculated in different animal models, such as the top-load model, the 50% exchange transfusion model and the haemorrhagic shock model. The results showed that the kinetic process of pPolyHb in rats conforms to the laws of linear pharmacokinetics in vivo. The half-life of pPolyHb was superior and more stable under non-pathological conditions, but in clinical situations such as trauma and anaemia, the half-life of pPolyHb may decline. The study of clearance (CL) and the apparent volume of distribution (Vd) of pPolyHb in these three different animal models demonstrated longer residence and a predominant, targeted role of pPolyHb with little accumulation in tissues. Through this study, the superior pharmacokinetic characteristics of pPolyHb have been proved and will aid in the determination of a reasonable dosing regimen and administration interval in clinical situations.

PMID: 29527952 [PubMed - as supplied by publisher]

http://ift.tt/2Dno6wv